Understanding Biosimilars: Essential Insights for Patients | ZERO Prostate Cancer Summit 2024

Join Sarah Ikenberry, M.A., Senior Communication Advisor at the Office of Therapeutic Biologics and Biosimilars within the Office of New Drugs CDER/FDA, as she delves into essential insights on biosimilars. This session, brought to you by Sandoz, provides valuable information for patients navigating the complex landscape of biosimilars.
Explore more enlightening sessions like this at the ZERO Prostate Cancer 2024 Virtual Education & Support Summit. Visit zerocancer.org/virtualsummit to learn more and be a part of the conversation.